Sermorelin
Sermorelin structure
|
Common Name | Sermorelin | ||
|---|---|---|---|---|
| CAS Number | 86168-78-7 | Molecular Weight | 3357.882 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C149H246N44O42S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of SermorelinSermorelin is a Growth Hormone Releasing Hormone (GHRH) produced by the brain that stimulates the production and release of Growth Hormone (GH). |
| Name | sermorelin |
|---|---|
| Synonym | More Synonyms |
| Description | Sermorelin is a Growth Hormone Releasing Hormone (GHRH) produced by the brain that stimulates the production and release of Growth Hormone (GH). |
|---|---|
| Related Catalog |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C149H246N44O42S |
| Molecular Weight | 3357.882 |
| Exact Mass | 3355.818604 |
| PSA | 1472.20000 |
| LogP | -3.92 |
| Index of Refraction | 1.650 |
| InChIKey | WGWPRVFKDLAUQJ-TWFXBKMCSA-N |
| SMILES | CCC(C)C(NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(N)=O)C(C)CC)C(C)C)C(C)O |
| Storage condition | −20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice
Behav. Brain Res. 233(1) , 232-6, (2012) Highlights ► The involvement of transmitters in the anxiolytic action of GH-RH antagonist, MZ-4-71, has been tested in plus maze. ► In the experiments the animals were pretreated with phenoxybenzamine... |
|
|
Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
Int. J. Cancer 132(4) , 755-65, (2013) New approaches are needed to the therapy of advanced prostate cancer. This study determined the effect of growth hormone-releasing hormone (GHRH) antagonists, JMR-132 and JV-1-38 on growth of PC3 tumo... |
|
|
Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Cancer 118(3) , 670-80, (2012) Antagonists of growth hormone-releasing hormone (GHRH) inhibit the proliferation of various human cancer cell lines and experimental tumors by mechanisms that include direct action on GHRH receptors i... |
| TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-NH2 |
| Sermorelina |
| Sermorelinum |
| Tyrosylalanyl-α-aspartylalanylisoleucylphenylalanylthreonylasparaginylseryltyrosylarginyllysylvalylleucylglycylglutaminylleucylserylalanylarginyllysylleucylleucylglutaminyl-α-aspartylisoleucyl methionylserylargininamide |
| Argininamide, tyrosylalanyl-α-aspartylalanylisoleucylphenylalanylthreonylasparaginylseryltyrosylarginyllysylvalylleucylglycylglutaminylleucylserylalanylarginyllysylleucylleucylglutaminyl-α-asp artylisoleucylmethionylseryl- |
| Sermoreline |
| MFCD00076559 |
| YaDAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |